“ECDGA provides important resources for my patients that has led to faster diagnosis. It also provides a community for patients with a rare disease to feel less alone.” – Mark Heaney, MD, 2019 Attendee
Presenter | Presentation Slides |
Jithma P. Abeykoon, MD | Histopathologic Mimics of Erdheim-Chester Disease (ECD) |
Benjamin H. Durham | Novel Alterations in CSF1R, RET, and Other Diverse Kinases in the Histiocytoses with Biochemical and Structural Insights into Their Mechanisms of Activation |
Marina Ferrarini, MD | 3D culture of BRAF/KRAS-mutated Erdheim-Chester disease tissues unveils rewired histiocyte metabolism as new therapeutic target |
Filip Janku, MD, PhD | MEK inhibition with trametinib in patients with non-Langerhans cell histiocytosis irrespective of BRAF mutation status |
Francesco Pegoraro, MD | Erdheim-Chester with multiple lesions related to BRAF V600E mutation. A simple coincidence? |
ECD GLOBAL ALLIANCE DOES NOT PROVIDE MEDICAL ADVICE, DIAGNOSIS OR TREATMENT.See Terms of Use and Privacy Policy
Website Maintained by Ask the Egghead, Inc.